375 related articles for article (PubMed ID: 26341632)
1. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
[TBL] [Abstract][Full Text] [Related]
2. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
[TBL] [Abstract][Full Text] [Related]
3. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
Monnier VM; Genuth S; Sell DR
Glycoconj J; 2016 Aug; 33(4):569-79. PubMed ID: 27342131
[TBL] [Abstract][Full Text] [Related]
4. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
5. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
[TBL] [Abstract][Full Text] [Related]
6. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
7. Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes.
Sveen KA; Dahl-Jørgensen K; Stensaeth KH; Angel K; Seljeflot I; Sell DR; Monnier VM; Hanssen KF
J Diabetes Complications; 2015 Apr; 29(3):407-12. PubMed ID: 25600701
[TBL] [Abstract][Full Text] [Related]
8. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
9. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
[TBL] [Abstract][Full Text] [Related]
10. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
[TBL] [Abstract][Full Text] [Related]
11. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
[TBL] [Abstract][Full Text] [Related]
13. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Umayahara Y; Kosugi K; Yamasaki Y
Atherosclerosis; 2009 May; 204(1):288-92. PubMed ID: 18926539
[TBL] [Abstract][Full Text] [Related]
14. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
Polak JF; Backlund JC; Budoff M; Raskin P; Bebu I; Lachin JM;
J Am Heart Assoc; 2021 Dec; 10(24):e022922. PubMed ID: 34873921
[TBL] [Abstract][Full Text] [Related]
15. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
Purnell JQ; Zinman B; Brunzell JD;
Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
[TBL] [Abstract][Full Text] [Related]
16. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
Yoshida N; Okumura K; Aso Y
Metabolism; 2005 Mar; 54(3):345-50. PubMed ID: 15736112
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
Temma J; Matsuhisa M; Horie T; Kuroda A; Mori H; Tamaki M; Endo I; Aihara K; Abe M; Matsumoto T
J Med Invest; 2015; 62(3-4):126-9. PubMed ID: 26399335
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).
Feldman DI; Cainzos-Achirica M; Billups KL; DeFilippis AP; Chitaley K; Greenland P; Stein JH; Budoff MJ; Dardari Z; Miner M; Blumenthal RS; Nasir K; Blaha MJ
Clin Cardiol; 2016 May; 39(5):291-8. PubMed ID: 27145089
[TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
[TBL] [Abstract][Full Text] [Related]
20. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
